Cite
MLA Citation
Frank Behrens et al.. “Minimal disease activity is a stable measure of therapeutic response in psoriatic arthritis patients receiving treatment with adalimumab.” Rheumatology, vol. 57, 2018, pp. 1938–1946. http://access.bl.uk/ark:/81055/vdc_100095322448.0x00001e